Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors.

International journal of oncology

Volumn 18, Issue 4, 2001, Pages 793-800

  Gaci, Z ^a   Bouin Pineau, M H ^a   Gaci, M ^a   Daban, A ^a   Ingrand, P ^a   Metaye T ^a  

^a University of Poitiers   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN; TFF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

AGED; ARTICLE; BREAST TUMOR; CANCER STAGING; CHEMISTRY; DISEASE FREE SURVIVAL; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LYMPH NODE; METABOLISM; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; TUMOR RECURRENCE;

AGED; BREAST NEOPLASMS; CATHEPSIN D; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; TUMOR SUPPRESSOR PROTEINS;

MLCS; MLOWN;

EID: 0035315762     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.18.4.793     Document Type: Article

References (0)